J. Lichtenfeld

发表

Information on Cost-Effectiveness: An Essential Product of a National Comparative Effectiveness Program

W. Hersh, S. Pauker, P. Basch, 2008, Annals of Internal Medicine.

Functional CD4 T Cells after Intercellular Molecular Transfer of OX40 Ligand1

E. Baba, K. Sugamura, Yuetsu Tanaka, 2001, The Journal of Immunology.

A profile of skin cancer prevention media coverage in 2009.

Kimberly S. Andrews, V. Cokkinides, J. Lichtenfeld, 2012, Journal of American Academy of Dermatology.

Molecular Transfer of OX40 Ligand Functional CD4 T Cells after Intercellular

E. Baba, K. Sugamura, Yuetsu Tanaka, 2022 .

Digital Health Applications in Oncology: An Opportunity to Seize

Ravi B. Parikh, B. Malin, M. Levy, 2022, Journal of the National Cancer Institute.

Policies and Practices to Address Cancer's Long-term Adverse Consequences.

S. Bhatia, L. Shulman, C. Bradley, 2022, Journal of the National Cancer Institute.

When disaster strikes: The role of disaster planning and management in cancer care delivery

A. Jemal, K. R. Yabroff, J. Lichtenfeld, 2020, Cancer.

Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase

H. Uhlig, T. Richter, T. Mothes, 2000, European journal of gastroenterology & hepatology.

Antibody response in patients with acute nonlymphocytic leukemia

M. Mardiney, C. Schiffer, P. Wiernik, 1976, Cancer.

Familial Sjögren's syndrome with associated primary salivary gland lymphoma.

R. Kirschner, J. Lichtenfeld, P. Wiernik, 1976, The American journal of medicine.

Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.

M. O’connell, C. Schiffer, J. Aisner, 1976, Cancer treatment reports.

Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro.

M. Mardiney, J. Lichtenfeld, P. Wiernik, 1976, Cancer treatment reports.

Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule.

D. V. Van Echo, P. Wiernik, J. Lichtenfeld, 1979, Cancer research.

The promise of Immuno-oncology: implications for defining the value of cancer treatment

Prasun Subedi, Richard L Schilsky, James Wu, 2019, Journal of Immunotherapy for Cancer.

Cutaneous melanomas attributable to ultraviolet radiation exposure by state

A. Jemal, K. Miller, F. Islami, 2020, International journal of cancer.

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

J. Griggs, C. Flowers, W. McCaskill-Stevens, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Wilms's tumor in three children of a woman with congenital hemihypertrophy.

C. Koop, A. Meadows, J. Lichtenfeld, 1974, The New England journal of medicine.

Reissner’s substance expressed as a transient pattern in vertebrate floor plate

W. Naumann, J. Lichtenfeld, J. Viehweg, 1999, Anatomy and Embryology.

The American Cancer Society 2035 challenge goal on cancer mortality reduction

A. Jemal, F. Islami, Jiemin Ma, 2019, CA: a cancer journal for clinicians.

Part 3 : Pathways to Achieving the Challenge Goal : Defining the Roadmap

A. Jemal, F. Islami, Jiemin Ma, 2019 .

Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

J. Griggs, C. Flowers, W. McCaskill-Stevens, 2017, Cancer research.

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute

J. Griggs, C. Flowers, W. McCaskill-Stevens, 2017, CA: a cancer journal for clinicians.

Phase I trial of pentamethylmelamine in patients with previously treated malignancies.

D. V. Van Echo, J. Aisner, P. Wiernik, 1980, Cancer treatment reports.

Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma.

M. Mardiney, J. Lichtenfeld, P. Wiernik, 1976, Cancer research.

Combined modality therapy for localized Hodgkin's disease. A seven-year update of an early study.

J. Lichtenfeld, P. Wiernik, 1975, Oncology.

Brief Communication: A New Apparatus for BCG Scarification

M. Mardiney, J. Lichtenfeld, M. Desner, 1975 .

Abnormal profile of human nucleolytic activity as a test for cancer.

M. Mardiney, J. Lichtenfeld, W. Drake, 1975, Journal of the National Cancer Institute.

Strategies for Improving Access to Hereditary Cancer Testing: Recommendations from Stakeholders

K. Ready, Natasha F Bonhomme, J. Lichtenfeld, 2019, Genetics in Medicine.